UAB researchers say metformin reduces risk of death for COVID patients with diabetes
UAB researchers said if people with Type 2 diabetes use the drug metformin before a COVID diagnosis, the mortality rate for Type 2 diabetes subjects dramatically decreased by three times as much.
“If someone is eligible to be on metformin, they should be on metformin, they should continue to take it,” said Anath Shalev, M.D., director of UAB’s Comprehensive Diabetes Center and leader of the study. “It may actually give you some protection.”
This content was originally published here.